Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and HIV

1-methyl-3-isobutylxanthine has been researched along with HIV in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bryn, T1
Mahic, M1
Aandahl, EM1
Frøland, SS1
Aukrust, P1
Taskén, K1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and HIV

ArticleYear
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients.
    AIDS research and human retroviruses, 2008, Volume: 24, Issue:7

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cells, C

2008